The Latest Breaking News from CVS Health

The uncertainty surrounding the market and the economy because the Federal Reserve signaled to continue hiking interest rates is making investors seek low-risk investments. Given lower volatility and attractive dividend payments, Johnson & Johnson (JNJ), CVS Health (CVS), and Summit Financial Group (SMMF) could be good candidates to consider on…

A nurse practitioner from northern Virginia has sued CVS Health after she says she was fired for refusing to provide abortion-inducing drugs at its MinuteClinic medical facilities

Fed’s drawn-out battle against inflation is expected to keep the stock market on edge. However, a renewed focus on domestic production and significant incentives from the government are likely to keep the wind in the sails of growth stocks. Hence, it would be wise to ignore the noise and hold…

The recent rally in the benchmark indices indicates improving investors’ sentiments. Moreover, analysts believe the economy could likely dodge a recession. So, it could be wise to consider buying quality stocks CVS Health (CVS), APA (APA), Biogen (BIIB), and Centene (CNC) now. Keep reading….

  A whale with a lot of money to spend has taken a noticeably bearish stance on CVS Health. Looking at options history for CVS Health (NYSE:CVS) we detected 10 strange trades.

Leading healthcare company CVS Health (CVS) reported strong second-quarter results and raised its fiscal 2022 full-year EPS and cash from operations guidance. Moreover, the company expects considerable growth across all its business segments, driven by its differentiated business model. Given the competitive advantages of its products and services, CVS continues…

Major indexes jumped at the week's opening, they pared most gains.

Stock futures higher ahead as investors assess the 'Inflation Reduction Act,' Softbank posts massive fiscal loss, and CVS Health ponders bid for Signal Health.

After more than a decade of astronomical growth, the stock market has steadily declined since early 2022. On June 13, the S&P 500 plunged into a bear market, closing by slightly less than 4%, representing a 21% drop from Jan. 3 high. Technology and Blue-chip stocks got hit as severely,…

CVS Health thumped second-quarter expectations and hiked its full-year forecast as growing prescription claims helped balance a drop in vaccinations

Someone with a lot of money to spend has taken a bullish stance on CVS Health (NYSE:CVS). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.